Table 2 EBUS-TBNA performance of the suspect LNs
Sensitivity | 94.02% |
Specificity | 100% |
NPV | 87.93% |
PPV | 100% |
Final diagnosis | |
Malignant | |
Other malignancies | 35 |
Colon and rectal adenocarcinoma | 5 |
Esophageal cancer | 3 |
SCC† of head and neck | 5 |
Cervical carcinoma | 5 |
Breast cancer | 4 |
Prostatic cancer | 2 |
Liver cancer | 4 |
Renal cancer | 3 |
Malignant melanoma | 2 |
Hemangiopericytoma | 1 |
Thymic SCC† | 1 |
Lung cancer | 75 |
AC‡ | 30 |
SCC† | 18 |
SCLC§ | 12 |
NSCLC※ | 10 |
Others | 5 |
Benign | 51 |
Sarcoid-like | 11 |
Surveillance¤ | 27 |
Surgery | 13 |